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Abstract
Neonatal primary hyperparathyroidism (NPHP) is a rare
disease that presents in the first 6 months of life. It is almost
invariably fatal unless a prompt diagnosis is made and urgent
surgical intervention is instituted. Patients with
hyperparathyroidism
require
special
preoperative
considerations. They require proper work-up from cardiac, renal
and neurological point of view, correction of intravenous
volume and electrolytes irregularities.
We are presenting a case of an infant who started to have
cyanosis and lethargy at 21st day of life. Initial diagnosis of
pneumonia was made but later on diagnosed as
hyperparathyroidism. He was planned for parathyroidectomy
under general anaesthesia. He was induced with sevoflurane
followed by fentanyl and atracurium and intubated with size 3.5
mm endotracheal tube (ETT). Later, he was maintained with
isoflurane and O2/NO2. He was successfully extubated at the
end of operation and was shifted to intensive care unit (ICU) for
close monitoring.
Keywords: Hyperparathyroidism, Anaesthetic management,
Hypercalcemia.

Introduction
Neonatal primary hyperparathyroidism (NPHP) is a rare
but life threatening presentation in which neonates have marked
hypercalcaemia, very high levels of parathyroid hormone,
hypotonia and respiratory distress.1 About 50 neonates with
NPHP have been reported and it has been suggested as a
possible contributor to a small number of cases of the Sudden
infant death syndrome (SIDS) as well.2
The etiology is genetic and results from inactivating
mutation of calcium sensing receptor gene (CaSR), in which the
inhibitory effect of extracellular calcium on the secretion of PTH
by chief cell is absent.3 Most reported cases have been of term
infants,4 there has been 1 report of an affected premature infant.5
In NPHP, medical therapy is inadequate and surgical
modality should be considered. Medical therapy without
surgical intervention has a high mortality rate (70-87 %) and
results in severe long term complications in the survivors.6
Parathyroidectomy with auto transplantation provides effective
treatment for primary and secondary hyperparathyroidism with
a predictable response of symptoms related to hypercalcaemia
and elevated parathyroid hormone.7 This intervention must be
Vol. 62, No. 10, October 2012

undertaken immediately to avoid death or irreversible long term
complications such as nephrocalcinosis, cardiac abnormalities,
bone resorption or central nervous system alterations.6

Case History
This is a case of a 21 days old infant who was brought
initially to local district hospital with cyanosis of face, palms
and soles, lethargy and irritability. An initial diagnosis of
pneumonia was made and treatment started but symptoms did
not improve much. He was referred to us in a tertiary hospital of
Karachi Aga Khan University almost 15 days after starting
treatment. On initial examination, his weight was 3.8 kilograms.
He was vitally stable with heart rate of 125 beats per minute,
blood pressure 98/58 mmHg, respiratory rate 36 per minute. His
breathing pattern was normal with oxygen saturation
maintained at 99% without any need of supplemental oxygen.
The child was active and there was no neurological deficit. His
sucking was strong and sustained. Chest auscultation revealed
occasional fine crepts at right base of lung but chest X-ray
findings were normal. Blood investigations showed high serum
calcium (15.5mg/dl), Parathyroid hormone (PTH) (1690
pg/ml), alkaline phosphatase and low urinary calcium and
phosphate. Other investigations included haemoglobin 13.2
g/dl, sodium 127 mmol/L, potassium 3.8 mmol/L, chloride 97
mmol/L, bicarbonate 19 mmol/L, BUN 5 mg/dL and creatinine
0.4 mg/dL. The rest of endocrinological profile was found to be
normal. Ultrasound Kidney Ureter and Bladder (KUB) showed
bilateral nephrocalcinosis. Hence, hyperparathyroidism was
diagnosed and total parathyroidectomy was planned.
Preoperatively, intravenous 1/5 dextrose saline was
started at the rate of 25ml/hour along with few doses of
intravenous furosemide in the ward to correct hypercalcemia.
Echocardiogram was done which was found normal. General
anaesthesia was planned and inhalational induction was done
with sevoflurane accompanied by injection atracurium 2
milligrams and fentanyl 2 micrograms. Patient was intubated
with size 3.5 PVC endotracheal tube. Anaesthesia was
maintained with O2/NO2 in 40/60% with isoflurane and
additional 2 micrograms fentanyl and 1 miligram atracurium
were given intravenously. Parathyroidectomy was done and part
of gland was implanted in right brachioradialis muscle.
Intraoperatively, patient received intravenous 1/2 dextrose
saline at a rate of 40 ml/hr. Patient remained haemodynamically
stable and temperature was maintained between 35.2 to 35.5°C
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throughout the procedure. At the end of the procedure, patient
was reversed with injection Neo-atropine and was extubated
when he started opening his eyes and flexing arms and hips.
On shifting to recovery room, his heart rate was 145
beats per minute, blood pressure 65/30 mmHg and oxygen
saturation 99 %. There were two very brief episodes of apnea in
recovery room so he was planned to be shifted to intensive care
unit for apnea monitoring and serial calcium levels. He received
two additional intravenous doses of 0.2 micrograms Fentanyl
for postoperative pain and was then continued on regular
paracetamol suppositories. He remained stable in intensive care
unit and serum calcium levels gradually dropped to 10.1 mg/dl
while low serum potassium was replaced. His intravenous fluid
was changed back to 1/5 dextrose saline at a rate of 15ml/hour
in intensive care unit. He also received alpha-calcidol and Cagluconate postoperatively. Later on, he was discharged home on
6th postoperative day on oral calcium-gluconate.

Discussion
Two recent changes have radically reduced anaesthesia
involvement in the care of patients with primary
hyperparathyroidism. One is the role of the calcimimetics
especially in older individuals and the other is to use minimally
invasive approaches after imaging procedures with just local
anaesthesia or a cervical plexus block.8
Patients with moderate hypercalcemia who have normal
renal and cardiovascular function present no special
preoperative problems. The ECG can be examined
preoperatively and intraoperatively for shortened PR or QT
intervals. As severe hypercalcaemia can result in hypovolaemia,
so normal intravascular volume and electrolyte status should be
restored preoperatively as was treated in our case. Additionally,
proper work up from cardiac, renal and neurologic point of view
is very important. In emergency situations, vigorous expansion
of intravascular volume usually reduces serum calcium to a safe
level (< 14 mg/dl); administration of furosemide is also often
helpful in these situations. Other measures to decrease
reabsorption of bone include the bisphosphonates pamidronate
and zoledronate, salmon calcitonin, and plicamycin.9
General anaesthesia is most commonly used, but
cervical plexus block and local anaesthesia with hypnosis have
been used successfully in adults.10 Due to the unpredictable
response to neuromuscular blocking drugs in the hypercalcemic
patient, a conservative approach to muscle paralysis makes
sense. There is an increased requirement for vecuronium and
probably all nondepolarizing muscle relaxants during onset of
neuromuscular blockade but we used 2 miligram (0.5 miligram
per kilogram) of injection atracurium which did well in our
case. Acidosis decreases calcium binding to albumin thus
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increasing the levels of ionized calcium, which can cause life
threatening hypercalcaemia, hence it is important to maintain
normocarbia.11 Careful positioning of the osteopenic patient is
also necessary to avoid pathologic bone fractures.12
Postoperative complications include recurrent laryngeal
nerve injury, bleeding and transient or complete
hypoparathyroidism. Hence, there is a requirement of
measurement of serial serum calcium levels which was done in
this case. Unilateral recurrent laryngeal nerve injury is
characterized by hoarseness and usually requires no
intervention. Bilateral recurrent laryngeal nerve injury is a rare
complication, producing aphonia and requiring immediate
tracheal intubation. Patients with significant preoperative bone
disease may have hypocalcaemia after removal of the PTHsecreting glands. Thus, serum calcium, magnesium and
phosphorus levels should be closely monitored until stable.12

Conclusion
Neonatal primary hyperparathyroidism is a very rare
condition which requires special considerations in terms of
cardiac, neurological and renal systems irregularities. These
patients need cautious administration of neuromuscular agents
and intravenous fluids and electrolytes intraoperatively.
Postoperative close monitoring of vitals and serial serum
calcium levels are also very important.
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